Lurasidone as a potential therapy for bipolar disorder
Young Sup Woo, Hee Ryung Wang, Won-Myong Bahk Department of Psychiatry, Yeouido St Mary's Hospital, The Catholic University of Korea, Seoul, Korea Abstract: Lurasidone is a benzisothiazol derivative and an atypical antipsychotic approved by the US Food and Drug Administration for the acute t...
Saved in:
Main Authors: | Woo YS, Wang HR, Bahk WM |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/bc7a54e3b15f4ed8993d5ea38d81b303 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lurasidone for the treatment of bipolar depression: an evidence-based review
by: Franklin R, et al.
Published: (2015) -
Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
by: Wang HR, et al.
Published: (2015) -
Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines
by: Jeong JH, et al.
Published: (2015) -
Korean Medication Algorithm Project for Bipolar Disorder: third revision
by: Woo YS, et al.
Published: (2015) -
Prevalence of bipolar spectrum disorder in Korean college students according to the K-MDQ
by: Bae SO, et al.
Published: (2013)